Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 22Completed 22Unknown 20Active not recruiting 13Not yet recruiting 10Terminated 8Withdrawn 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Carcinoma 1

Interventions

Radiotherapy 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2lenvatinib 1Specimen Handling 1Sorafenib 1Platinum 1Photochemotherapy 1Oxycodone 1NUC-1031 1Ketorolac 1Ketamine 1Ipilimumab 1Gemcitabine 1Folfox protocol 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × Cisplatin × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡